Farmers National Bank Kintara Therapeutics, Inc. Transaction History

Farmers National Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Aug 28, 2024	SELL	$0.1 - $14.8 $1,125 - $166,500	-11,250 Closed	0 $0
Q2 2022 Aug 28, 2024	BUY	$0.14 - $0.5 $1,575 - $5,625	11,250 New	11,250 $3.13 Million
Q4 2021 Aug 28, 2024	BUY	$0.51 - $1.04 $153 - $312	300 Added 2.74%	11,250 $5.74 Million
Q3 2021 Aug 28, 2024	BUY	$0.82 - $2.3 $8,979 - $25,184	10,950 New	10,950 $9,000
Q2 2021 Aug 28, 2024	SELL	$1.26 - $2.4 $14,175 - $27,000	-11,250 Closed	0 $0
Q1 2021 Aug 28, 2024	BUY	$1.32 - $2.74 $14,850 - $30,825	11,250 New	11,250 $19.6 Million
Q4 2020 Aug 28, 2024	BUY	$1.26 - $1.72 $13,797 - $18,834	10,950 New	10,950 $14 Million

Ticker KTRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,807,296
Market Cap $17.8M
Description
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme,...

Get notified when there are updates to the investment portfolio of Farmers National Bank, based on Form 13F filings with the SEC.

Stay updated on Farmers National Bank with notifications on news.